1 The FNR Foresight Thinking for the Future Today – A Participative Process.
Strategic thinking in pharmaceutical industry today
1
“The global generic pharmaceuticals market is likely to experience strong growth in the next few years, estimated up to US$231 billion in 2017.” This prediction is based on impending patent expiration of key blockbuster drugs worth US$150 billion, as well as government efforts to reduce the drug bill. Strategic thinking in pharmaceutical industry today … Most of us in Pharma industry today, if NOT all, claim that we have robust-strategic-vision. Conversely, we almost always find that many of apparently effective companies do not even have merely a clear plan. Have a look at the key-facts of today’s industry; R&D investment model of Big-Pharma is on its last legs A substantial reduction of productivity in NCEs discovery A diverging and declining global market An aging population outpacing health care expenditures vs. GDP An increasing pricing pressure “Strategic thinking is the process that extracts the best innovative & thoughtful rationale thinking vis-à-vis what is happening in business and what direction the company should be heading in.” Strategic thinking identifies the key factors that dictate the future of an organization and enables management to put the corporation in a position of long-life and prosperity within changing environment. The new face of the Pharma industry is reflecting from varying factors. Thinking strategically has never existed as much it does today and short-terms tactics are least important. This is what most executives at the key positions in the Pharmaceutical industry today miss as they become used of working in a particular old style, analogous people, no-changing cultures and deceivingly unchanging environment. Syed Adeel Ahmed life-science business development professional [email protected] In semi-to-highly regulated territories generics shift remains opportunity for growth in territories with underdeveloped healthcare systems. Competition is high and big companies are using different strategies: some big companies have a diversified portfolio strategy, some have a niche portfolio strategy, some have an outsourcing strategy, and some employ all three
-
Upload
adeel-ahmed -
Category
Business
-
view
1.120 -
download
0
description
Transcript of Strategic thinking in pharmaceutical industry today
“The global generic
pharmaceuticals market is
likely to experience strong
growth in the next few years,
estimated up to US$231 billion
in 2017.”
This prediction is based on
impending patent expiration of
key blockbuster drugs worth
US$150 billion, as well as
government efforts to reduce
the drug bill.
Strategic thinking in pharmaceutical industry today …
Most of us in Pharma industry today, if NOT all, claim that we have robust-strategic-vision.
Conversely, we almost always find that many of apparently effective companies do not even
have merely a clear plan.
Have a look at the key-facts of today’s industry;
R&D investment model of Big-Pharma is on its
last legs
A substantial reduction of productivity in NCEs
discovery
A diverging and declining global market
An aging population outpacing health care
expenditures vs. GDP
An increasing pricing pressure
“Strategic thinking is the process that extracts the best
innovative & thoughtful rationale thinking vis-à-vis what
is happening in business and what direction the
company should be heading in.”
Strategic thinking identifies the key factors that dictate the future of an organization and
enables management to put the corporation in a position of long-life and prosperity within
changing environment.
The new face of the Pharma industry is reflecting from varying factors. Thinking strategically has
never existed as much it does today and short-terms tactics are least important.
This is what most executives at the key positions in the Pharmaceutical industry today miss as
they become used of working in a particular old style, analogous people, no-changing cultures
and deceivingly unchanging environment.
Syed Adeel Ahmed
life-science business development professional [email protected]
In semi-to-highly regulated territories generics shift remains opportunity for growth in territories with underdeveloped healthcare systems. Competition is high and big companies are using different strategies:
some big companies have a diversified portfolio strategy, some have a niche portfolio strategy, some have an outsourcing strategy, and some employ all three
